SCHEMBL15944204

SCHEMBL15944204

CC(=O)N1C/C(=C\c2ccc([N+](=O)[O-])cc2)C(=O)/C1=C/c1ccc(C)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 2/20 0.53
USP18 Q9UMW8 2/20 0.47
UCHL5 Q9Y5K5 2/20 0.47
ACHE P22303 2/20 0.45
HSP90AA1 P07900 3/20 0.45
USP2 O75604 1/20 0.45
MAPT P10636 7/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
RAB9A P51151 3/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
MAOB P27338 2/20 0.43
MAOA P21397 1/20 0.43
HSD17B10 Q99714 1/20 0.42
ALDH1A1 P00352 4/20 0.42
MAPK1 P28482 4/20 0.42
LMNA P02545 3/20 0.42
GAA P10253 2/20 0.42
NPC1 O15118 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18802990 0.79 CASP3 (0.72) CASP3USP18UCHL5ACHEHSP90AA1
SCHEMBL22822868 0.73 HSP90AA1 (0.66) CASP3USP18UCHL5ACHEHSP90AA1
SCHEMBL19953977 0.71 CASP3 (0.52) CASP3USP18UCHL5ACHEHSP90AA1
SCHEMBL22823111 0.70 CASP3 (0.59) CASP3USP18UCHL5ACHEHSP90AA1
SCHEMBL17873942 0.69 CASP3 (1.00) CASP3USP18UCHL5ACHEHSP90AA1
SCHEMBL14798452 0.69 CASP3 (1.00) CASP3USP18UCHL5ACHEHSP90AA1
SCHEMBL14798453 0.69 CASP3 (1.00) CASP3USP18UCHL5ACHEHSP90AA1
SCHEMBL29354956 0.69 CASP3 (1.00) CASP3USP18UCHL5ACHEHSP90AA1
SCHEMBL9186136 0.69 KMT2A (0.55) CASP3USP18UCHL5HSP90AA1USP2
SCHEMBL9186135 0.69 KMT2A (0.55) CASP3USP18UCHL5HSP90AA1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140228354-A1 Method for Inhibition of Deubiquitinating Activity VIVOLUX AB (SE) 2014-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140228354-A1 Method for Inhibition of Deubiquitinating Activity USP19, USP1, USP18 CASP3 774/4885USP18 3/4885UCHL5 23/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.